Boris Gershman
Overview
Explore the profile of Boris Gershman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
1268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiesen B, Flaig T, Gershman B, Konety B, Warren A, Kuna E, et al.
Adv Urol
. 2024 Dec;
2024:8871425.
PMID: 39735345
Although clinical trials should be accessible to all patients, persistent racial and ethnic disparities in clinical trial enrollment exist. Herein, we examine racial disparities in clinical trial enrollment among prostate...
2.
Eule C, Warren A, Kuna E, Robin T, Gershman B, Kim S, et al.
Prostate Cancer Prostatic Dis
. 2024 Nov;
PMID: 39572637
Background: Small cell prostate cancer (SCPC) is a rare, aggressive disease with limited clinical data to guide treatment. In this retrospective study, we evaluated clinical, treatment, and outcomes data for...
3.
Perez-Londono A, Ramos F, Fleishman A, Kaul S, Korets R, Johnson M, et al.
Can Urol Assoc J
. 2024 Nov;
19(3):E85-E91.
PMID: 39527483
Introduction: Although the Prostate Imaging-Reporting and Data System (PI-RADS) categorization represents the standard method for assessing the risk of prostate cancer using prostate magnetic resonance imaging (MRI), there exists wide...
4.
Al-Faouri R, Sharkey C, Gershman B, Tsai L, Wang Z, Olumi A
Eur Urol Focus
. 2024 Nov;
10(4):641-647.
PMID: 39492303
Background: Inflammation has been linked to the development of benign prostatic hyperplasia (BPH). SRD5A2 is a pivotal enzyme in the development and growth of the prostate gland and a critical...
5.
Ballon-Landa E, Hannemann A, Gershman B, Rodrigues Pessoa R, Olson B, Clark P, et al.
Urol Oncol
. 2024 Nov;
PMID: 39492009
Objectives: To increase the population-level understanding of upper tract imaging evaluation during risk-based hematuria assessment. Using a national, privately-insured cohort, we evaluated the rates of imaging and the diagnostic yield...
6.
Eule C, Kuna E, Robin T, Gershman B, Flaig T, Kim S
Urol Oncol
. 2024 Aug;
42(12):447.e17-447.e24.
PMID: 39191549
Background: In metastatic hormone-sensitive prostate cancer (mHSPC), androgen deprivation therapy and standard of care treatment intensification with docetaxel and/or an androgen receptor signaling inhibitor (ARSI) are associated with improved survival...
7.
Ernandez J, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, et al.
Bladder Cancer
. 2024 Jul;
8(4):405-417.
PMID: 38994178
Background: Survival with locally advanced bladder cancer (LABC) following radical cystectomy (RC) remains poor. Although adjuvant chemotherapy (AC) is standard of care, one small, randomized trial has suggested a potential...
8.
Gulati R, Jiao B, Al-Faouri R, Sharma V, Kaul S, Fleishman A, et al.
Ann Intern Med
. 2024 Jun;
177(7):871-881.
PMID: 38830219
Background: Contemporary prostate cancer (PCa) screening uses first-line prostate-specific antigen (PSA) testing, possibly followed by multiparametric magnetic resonance imaging (mpMRI) for men with elevated PSA levels. First-line biparametric MRI (bpMRI)...
9.
Perez-Londono A, Abello A, Gershman B, Korets R
Can J Urol
. 2024 Apr;
31(2):11848-11853.
PMID: 38642463
Holmium laser enucleation of the prostate (HoLEP) is considered a size-independent technique to treat benign prostatic hyperplasia. This safe and effective procedure is increasingly being adopted in urology training programs...
10.
Desmond C, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, et al.
Prostate Cancer Prostatic Dis
. 2024 Mar;
PMID: 38555410
Background: Although active surveillance is the preferred management for low-risk prostate cancer (PCa), some men remain at risk of overtreatment with definitive local therapy. We hypothesized that baseline characteristics may...